1. Home
  2. FTHM vs GDTC Comparison

FTHM vs GDTC Comparison

Compare FTHM & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

HOLD

Current Price

$1.09

Market Cap

36.9M

Sector

Finance

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.55

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTHM
GDTC
Founded
2010
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.9M
24.8M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
FTHM
GDTC
Price
$1.09
$1.55
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
93.3K
37.9K
Earning Date
11-11-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$421,612,000.00
$573,193.00
Revenue This Year
$30.07
$5.37
Revenue Next Year
$14.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
32.78
63.03
52 Week Low
$0.65
$1.38
52 Week High
$3.37
$4.05

Technical Indicators

Market Signals
Indicator
FTHM
GDTC
Relative Strength Index (RSI) 41.77 30.94
Support Level $1.04 $1.53
Resistance Level $1.17 $1.66
Average True Range (ATR) 0.07 0.14
MACD 0.00 -0.02
Stochastic Oscillator 29.79 4.05

Price Performance

Historical Comparison
FTHM
GDTC

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: